Speaker Profile

___	__
	Biography Mr. Paul Carr is the former President of the Electrical Div. of Guillevin International Co. headquartered in Montreal and spent 33 years of his career with Guillevin working his way up from Technical Sales to Management to Senior Management and Executive level. He is a registered Incorporated Engineer (I.Eng. MIET) with the Institute of Engineering Technology (a global Engineering Institute in London England). He established the Kitty Carr Fund at the Canadian Foundation for Women’s Health (www.cfwh.org) in memory of his wife. The Kitty Carr Fund will support research and initiatives focused on prevention of maternal mortality in Canada Disclosure 1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity: Shareholder in Merck and Johnson & Johnson 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Mr. Paul Carr is the former President of the Electrical Div. of Guillevin International Co. headquartered in Montreal and spent 33 years of his career with Guillevin working his way up from Technical Sales to Management to Senior Management and Executive level. He is a registered Incorporated Engineer (I.Eng. MIET) with the Institute of Engineering Technology (a global Engineering Institute in London England). He established the Kitty Carr Fund at the Canadian Foundation for Women’s Health (www.cfwh.org) in memory of his wife. The Kitty Carr Fund will support research and initiatives focused on prevention of maternal mortality in Canada
Disclosure
1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity: Shareholder in Merck and Johnson & Johnson 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).